Advertisement

The effect of motivational strategy on voluntary plasma donation, a field trial

      Abstract

      Background

      Plasma protein therapies (PPTs) are a group of medicines extracted from human plasma through fractionation. The manufacture of adequate amounts of PPTs requires a large volume of human plasma. WHO emphasized that whole blood and blood component donations should be voluntary and non-remunerated. So, motivating people to donate plasma is crucial. In this study, we evaluated the impact of social media on motivating blood donors to donate plasma without any compensation and the moderating effects of blood donation history on plasma donation.

      Methods and materials

      we allocated blood donors (n = 501) to intervention and control groups randomly. Participants in the intervention group got educational and motivational messages through a WhatsApp channel. Then, we followed up all participants for six months and registered the information of the plasma donation during this period.

      Result

      In the intervention group, 6.8% had returned to donate plasma, while this was 2% in the control group (p = 0.016, OR:3.59, 95%CI:1.3–9.89). Among regular blood donors in the intervention group, 17.86% had returned to donate plasma but, no regular donor returned to donate plasma in the control group (p = 0.055). In addition, 10.8% of donors who had academic education in the intervention group returned to donate plasma, although this was 2.54% in the control group (P = 0.0485).

      Conclusion

      Our findings suggest that the educational interventions have more effects on academically educated donors to motivate them to donate plasma.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Farrugia A.
        • Penrod J.
        • Bult J.M.
        The ethics of paid plasma donation: a plea for patient centeredness.
        HEC forum. Springer, 2015: 417-429
        • Farrugia A.
        • Penrod J.
        • Bult J.M.
        Payment, compensation and replacement–the ethics and motivation of blood and plasma donation.
        Vox Sang. 2010; 99: 202-211
        • Shaz B.H.
        • Domen R.E.
        • France C.R.
        Remunerating donors to ensure a safe and available blood supply.
        Transfusion. 2020; 60: S134-S137
        • Williams III, L.A.
        • Sikora J.
        • Aldrees R.
        • Pham H.P.
        • Marques M.B.
        Anti-Rh alloimmunization after trauma resuscitation.
        Transfus Apher Sci. 2019; 58102652
      1. Spinella P.C., Gurney J., Yazer M.H. Low titer group O whole blood for prehospital hemorrhagic shock: it is an offer we cannot refuse. Wiley Online Library; 2019.

        • Domen R.E.
        Paid-versus-volunteer blood donation in the United States: a historical review.
        Transfus Med Rev. 1995; 9: 53-59
        • Zhu C.S.
        • Pokorny D.M.
        • Eastridge B.J.
        • Nicholson S.E.
        • Epley E.
        • Forcum J.
        • et al.
        Give the trauma patient what they bleed, when and where they need it: establishing a comprehensive regional system of resuscitation based on patient need utilizing cold‐stored, low‐titer O+ whole blood.
        Transfusion. 2019; 59: 1429-1438
        • Ellingson K.D.
        • Sapiano M.R.P.
        • Haass K.A.
        • Savinkina A.A.
        • Baker M.L.
        • Chung K.
        • et al.
        Continued decline in blood collection and transfusion in the U nited S tates–2015.
        Transfusion. 2017; 57: 1588-1598
        • Sapiano M.R.P.
        • Savinkina A.A.
        • Ellingson K.D.
        • Haass K.A.
        • Baker M.L.
        • Henry R.A.
        • et al.
        Supplemental findings from the national blood collection and utilization surveys, 2013 and 2015.
        Transfusion. 2017; 57: 1599
        • Klein H.G.
        • Hrouda J.C.
        • Epstein J.S.
        Crisis in the sustainability of the US blood system.
        N Engl J Med. 2017; 377: 1485-1488
      2. Shaz B.H., Hillyer C.D. Transfusion medicine and hemostasis: clinical and laboratory aspects. Newnes; 2013.

      3. W.H.O. Blood safety and availability [Internet]. 2019. Available from: 〈https://www.who.int/en/news-room/fact-sheets/detail/blood-safety-and-availability〉.

      4. WHO Utilization and supply of human blood and blood products [internet]. 1975. Available from: http://www.who.int/bloodsafety/en/WHA28.72.pdf.

        • Group W.H.O.E.
        Expert Consensus Statement on achieving self‐sufficiency in safe blood and blood products, based on voluntary non‐remunerated blood donation (VNRBD).
        Vox Sang. 2012; 103: 337-342
        • Maghsudlu M.
        Keys to move to self‐sufficiency in safe blood components based on voluntary blood donation.
        ISBT Sci Ser. 2017; 12: 202-206
        • Cheraghali A.M.
        • Abolghasemi H.
        Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience.
        Haemophilia. 2009; 15: 487-493
        • Bagot K.L.
        • Masser B.M.
        • White K.M.
        • Starfelt L.C.
        Recruiting and retaining plasmapheresis donors: a critical belief analysis.
        Transfus Apher Sci. 2015; 52: 350-357
      5. ABOU ALGHASEMI H, MAGHSOUD LOUM, AMINI KS, Cheraghali A. Introduction to Iranian blood transfusion organization and blood safety in Iran. 2009;

        • Thorpe R.
        • Masser B.M.
        • Nguyen L.
        • Gemelli C.N.
        • Davison T.E.
        Bringing new plasma donors back: testing the efficacy of telephone and e‐mail communications with first‐time donors.
        Transfusion. 2020; 60: 1463-1469
        • Bagot K.L.
        • Bove L.L.
        • Masser B.M.
        • Bednall T.C.
        • Buzza M.
        Perceived deterrents to being a plasmapheresis donor in a voluntary, nonremunerated environment.
        Transfusion. 2013; 53: 1108-1119
      6. Thijsen A., Davison T.E., Speedy J., Hoad V., Masser B. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events. Vox Sang. 2020;

        • Maghsudlu M.
        • Nasizadeh S.
        Iranian blood donors’ motivations and their influencing factors.
        Transfus Med. 2011; 21: 247-252
        • Hashemi S.
        • Maghsudlu M.
        • Nasizadeh S.
        • Esmaielifar G.
        • Pourfathollah A.A.
        Effective ways to retain first‐time blood donors: a field‐trial study.
        Transfusion. 2019; 59: 2893-2898
        • Glynn S.A.
        • Kleinman S.H.
        • Schreiber G.B.
        • Zuck T.
        • Mc Combs S.
        • Bethel J.
        • et al.
        Motivations to donate blood: demographic comparisons.
        Transfusion. 2002; 42: 216-225
      7. Kasraian L., Ashkani-Esfahani S., Foruozandeh H. Reasons of under-representation of Iranian women in blood donation. Hematol Transfus Cell Ther. 2020;